Annual EBIT
-$167.60 M
+$33.29 M+16.57%
31 December 2023
Summary:
Mersana Therapeutics annual earnings before interest & taxes is currently -$167.60 million, with the most recent change of +$33.29 million (+16.57%) on 31 December 2023. During the last 3 years, it has fallen by -$79.91 million (-91.13%). MRSN annual EBIT is now -1112.63% below its all-time high of -$13.17 million.MRSN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.10 M
+$13.19 M+56.64%
30 September 2024
Summary:
Mersana Therapeutics quarterly earnings before interest & taxes is currently -$10.10 million, with the most recent change of +$13.19 million (+56.64%) on 30 September 2024. Over the past year, it has increased by +$30.54 million (+75.15%). MRSN quarterly EBIT is now -146.10% below its all-time high of $21.90 million, reached on 31 March 2019.MRSN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$70.18 M
+$30.54 M+30.32%
30 September 2024
Summary:
Mersana Therapeutics TTM earnings before interest & taxes is currently -$70.18 million, with the most recent change of +$30.54 million (+30.32%) on 30 September 2024. Over the past year, it has increased by +$122.88 million (+63.65%). MRSN TTM EBIT is now -1209.37% below its all-time high of -$5.36 million, reached on 31 March 2016.MRSN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.6% | +75.2% | +63.6% |
| 3 y3 years | -91.1% | +77.8% | +53.1% |
| 5 y5 years | -160.8% | +39.5% | -104.9% |
MRSN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -91.1% | +16.6% | at high | +82.9% | at high | +66.8% |
| 5 y | 5 years | -499.1% | +16.6% | at high | +82.9% | -150.9% | +66.8% |
| alltime | all time | -1112.6% | +16.6% | -146.1% | +82.9% | -1209.4% | +66.8% |
Mersana Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.10 M(-56.6%) | -$70.18 M(-30.3%) |
| June 2024 | - | -$23.29 M(+27.2%) | -$100.72 M(-22.9%) |
| Mar 2024 | - | -$18.30 M(-1.0%) | -$130.72 M(-22.0%) |
| Dec 2023 | -$167.60 M(-16.6%) | -$18.50 M(-54.5%) | -$167.60 M(-13.2%) |
| Sept 2023 | - | -$40.64 M(-23.7%) | -$193.06 M(-8.7%) |
| June 2023 | - | -$53.28 M(-3.4%) | -$211.35 M(+0.9%) |
| Mar 2023 | - | -$55.18 M(+25.5%) | -$209.53 M(+4.3%) |
| Dec 2022 | -$200.88 M(+19.0%) | -$43.96 M(-25.4%) | -$200.88 M(-2.0%) |
| Sept 2022 | - | -$58.93 M(+14.5%) | -$204.93 M(+7.1%) |
| June 2022 | - | -$51.46 M(+10.6%) | -$191.37 M(+5.9%) |
| Mar 2022 | - | -$46.53 M(-3.1%) | -$180.73 M(+7.1%) |
| Dec 2021 | -$168.79 M(+92.5%) | -$48.00 M(+5.8%) | -$168.79 M(+12.9%) |
| Sept 2021 | - | -$45.37 M(+11.2%) | -$149.54 M(+18.2%) |
| June 2021 | - | -$40.82 M(+18.0%) | -$126.56 M(+20.0%) |
| Mar 2021 | - | -$34.60 M(+20.3%) | -$105.45 M(+20.3%) |
| Dec 2020 | -$87.69 M | -$28.75 M(+28.4%) | -$87.68 M(+16.8%) |
| Sept 2020 | - | -$22.40 M(+13.7%) | -$75.09 M(+8.2%) |
| June 2020 | - | -$19.70 M(+17.0%) | -$69.38 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$16.84 M(+4.2%) | -$66.71 M(+138.5%) |
| Dec 2019 | -$27.97 M(-56.5%) | -$16.16 M(-3.2%) | -$27.97 M(-18.3%) |
| Sept 2019 | - | -$16.68 M(-2.0%) | -$34.25 M(-1.1%) |
| June 2019 | - | -$17.03 M(-177.8%) | -$34.63 M(+15.6%) |
| Mar 2019 | - | $21.90 M(-197.6%) | -$29.95 M(-53.6%) |
| Dec 2018 | -$64.26 M(+66.0%) | -$22.43 M(+31.4%) | -$64.62 M(+16.2%) |
| Sept 2018 | - | -$17.07 M(+38.2%) | -$55.63 M(+19.4%) |
| June 2018 | - | -$12.35 M(-3.2%) | -$46.61 M(+7.5%) |
| Mar 2018 | - | -$12.76 M(-5.0%) | -$43.36 M(+12.0%) |
| Dec 2017 | -$38.71 M(+180.1%) | -$13.44 M(+67.0%) | -$38.71 M(+60.9%) |
| Sept 2017 | - | -$8.05 M(-11.6%) | -$24.05 M(+9.9%) |
| June 2017 | - | -$9.10 M(+12.2%) | -$21.90 M(+32.1%) |
| Mar 2017 | - | -$8.11 M(-769.9%) | -$16.57 M(+19.9%) |
| Dec 2016 | -$13.82 M(-15.4%) | $1.21 M(-120.6%) | -$13.82 M(-8.1%) |
| Sept 2016 | - | -$5.89 M(+55.8%) | -$15.03 M(+64.4%) |
| June 2016 | - | -$3.78 M(-29.4%) | -$9.14 M(+70.6%) |
| Mar 2016 | - | -$5.36 M | -$5.36 M |
| Dec 2015 | -$16.34 M | - | - |
FAQ
- What is Mersana Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Mersana Therapeutics?
- What is Mersana Therapeutics annual EBIT year-on-year change?
- What is Mersana Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly EBIT year-on-year change?
- What is Mersana Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Mersana Therapeutics?
- What is Mersana Therapeutics TTM EBIT year-on-year change?
What is Mersana Therapeutics annual earnings before interest & taxes?
The current annual EBIT of MRSN is -$167.60 M
What is the all time high annual EBIT for Mersana Therapeutics?
Mersana Therapeutics all-time high annual earnings before interest & taxes is -$13.17 M
What is Mersana Therapeutics annual EBIT year-on-year change?
Over the past year, MRSN annual earnings before interest & taxes has changed by +$33.29 M (+16.57%)
What is Mersana Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MRSN is -$10.10 M
What is the all time high quarterly EBIT for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly earnings before interest & taxes is $21.90 M
What is Mersana Therapeutics quarterly EBIT year-on-year change?
Over the past year, MRSN quarterly earnings before interest & taxes has changed by +$30.54 M (+75.15%)
What is Mersana Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MRSN is -$70.18 M
What is the all time high TTM EBIT for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM earnings before interest & taxes is -$5.36 M
What is Mersana Therapeutics TTM EBIT year-on-year change?
Over the past year, MRSN TTM earnings before interest & taxes has changed by +$122.88 M (+63.65%)